Scientific Context and Clinical Relevance In early clinical trials, Retatrutide demonstrated significant effects on energy expenditure and glucose control when used in weekly dosing schedules
doi: 10.1016/0006-2952(86)90551-4
The HMB can be absorbed across ruminal, omasal, and abomasal epithelium (McCollum et al., 2000), being converted to Met in peripheral tissues (mainly nonhepatic tissues) after absorption (Lobley et al., 2006a)
While not listed as a direct adverse effect in FDA prescribing information, this cold sensitivity appears linked to the medication's weight loss effects rather than direct temperature regulation changes
King LE, Frentzel JW, Mann JJ, Fraker PJ
Adverse events reported none flagged at the studied doses